Clinical Trial Update: Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining radiation plus adebrelimab in metastatic castration-resistant prostate cancer with imaging-measurable disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)

Snippet

Sponsor: Fudan University | Conditions: Prostate Cancer Metastatic, Castration-resistant Prostate Cancer | Phase 2 | Status: UNKNOWN